Atlas Trials

Refractory Colorectal Carcinoma

11 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Refractory Colorectal Carcinoma

RecordFirmDate
Guadecitabine and Nivolumab in Treating Refractory Metastatic Colorectal Cancer (NCT03576963)University of Southern California2020-01-30
Fruquintinib Combined With TAS-102 in Refractory Metastatic Colorectal Cancer (NCT06221423)Fudan University2020-01-01
TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer (NCT04294264)Rutgers, The State University of New Jersey2019-02-12
Circulating Cell-Free Tumor DNA Testing in Guiding Treatment for Patients With Advanced or Metastatic Colorectal Cancer (NCT03844620)M.D. Anderson Cancer Center2019-01-29
Nivolumab and Metformin in Patients With Treatment Refractory MSS Colorectal Cancer (NCT03800602)Emory University2019-01-15
Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, or Pancreatic Ductal Adenocarcinoma (NCT03610490)M.D. Anderson Cancer Center2018-10-16
Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer (NCT02873195)Academic and Community Cancer Research United2017-07-07
M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery (NCT02595931)National Cancer Institute (NCI)2016-07-22

Track Refractory Colorectal Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.